| Previous Section | Index | Home Page |
18 Jul 2005 : Column 1464W—continued
Health Funding
Mr. Whittingdale: To ask the Secretary of State for Health what the financial surplus or deficit recorded by each (a) NHS trust and (b) primary care trust in Essex was for 2004–05. [12121]
Ms Rosie Winterton: The latest year for which audited data on the financial position of national health service organisations is available is 2003–04. The Department does not currently publish unaudited information.
Audited information in respect of the 2004–05 financial position of all strategic health authorities, primary care trusts and NHS trusts will be published in their individual annual accounts, and will be available centrally in autumn 2005.
Mr. Whittingdale: To ask the Secretary of State for Health how much financial support was received by each (a) NHS trust and (b) primary care trust in Essex from the Essex NHS Bank in 2004–05; and how much is owed by each to the Essex NHS Bank. [12122]
Ms Rosie Winterton: The NHS Bank provides special assistance to the most financially challenged strategic health authorities (SHAs). Essex SHA has not received any special assistance from the NHS Bank.
Mr. Whittingdale: To ask the Secretary of State for Health how much funding per capita was given to each primary care trust in Essex in 2004–05. [12123]
Ms Rosie Winterton: Essex primary care trust's (PCTs) allocation per head of population (per capita) for 2004–05 is shown in the table.
Source:
Department of Health Resource Allocation and Monitoring Analysis
Mr. Lancaster: To ask the Secretary of State for Health what the health expenditure per head of population in Milton Keynes has been in each year since 1997. [11570]
18 Jul 2005 : Column 1465W
Ms Rosie Winterton: Expenditure based on Milton Keynes is not available. The expenditure per weighted head on health in Buckinghamshire Health Authority (HA) area and Thames Valley Strategic Health Authority (SHA) area is shown in the table.
| Buckinghamshire HA | Thames Valley SHA area | |
|---|---|---|
| 1997–98 | 599.87 | n/a |
| 1998–99 | 637.24 | n/a |
| 1999–2000 | 699.93 | n/a |
| 2000–01 | 755.09 | n/a |
| 2001–02 | 976.85 | n/a |
| 2002–03 | n/a | 904.32 |
| 2003–04 | n/a | 1,140.04 |
Notes:
1.Expenditure has been taken from audited health authority summarisation forms and primary care trust summarisation schedules, which are prepared on a resource basis and therefore differ from cash allocations in the year. The figures have not been adjusted for inflation.
2.Figures for 1997–98 to 2001–02 have been prepared using gross expenditure figures. Figures for 2002–03 and 2003–04 have been adjusted to eliminate expenditure, which would be double counted where an authority acts as a lead in commissioning healthcare or other services. In 2001–02, there was a high degree of inter authority transactions, which have increased the apparent expenditure per head.
3.In many HAs there are factors, which distort the expenditure. These include:
the HA acting in a lead capacity to commission healthcare or fund training on behalf of other health bodies; and
asset revaluations in national health service trusts being funded through HAs or PCTs.
4.The majority of general dental services expenditure is separately accounted for by the Dental Practice Board. An element of pharmaceutical services expenditure is accounted for by the Prescription Pricing Authority. Total expenditure on these items by the Dental Practice Board and the Prescription Pricing Authority cannot be allocated to individual health bodies, therefore the total expenditure in the answer by health authority does not capture all NHS expenditure within the area.
Sources:
Buckinghamshire HA audited accounts 1997–98 and 1998–99.
Buckinghamshire HA audited summarisation forms 1999–2000 to 2001–02.
Thames Valley SHA audited summarisation forms 2002–03 and 2003–04
Primary care trust (PCT) audited summarisation schedules 2000–01 to 2003–04 for bodies within the above health authority areas.
Weighted population figures.
Hepatitis B
Mr. Amess: To ask the Secretary of State for Health (1) what the incidence of hepatitis B in England was in the last period for which figures are available; and what measures are being taken to control its spread; [10001]
(2) if she will commission a national strategy for hepatitis B. [10003]
Caroline Flint: Information on the incidence of hepatitis B in England is available from the Health Protection Agency's website at: www.hpa.org.uk/infections/topics_az/hepatitis_b/data.htm.
There are a range of measures being taken to control the spread of hepatitis B in England, these include:
18 Jul 2005 : Column 1466W
The joint committee on vaccination and immunisation is reviewing the hepatitis B immunisation programme to assess whether it needs to be altered.
The National Institute for Health and Clinical Excellence is appraising the clinical and cost effectiveness of adefovir dipivoxil and pegylated interferon for the treatment of chronic hepatitis B infection. Guidance is expected in February 2006.
We have no current plans to commission a national strategy for hepatitis B but policy is kept under ongoing review.
Mr. Amess: To ask the Secretary of State for Health how many patients, other than those who have received transplants, are being treated for chronic hepatitis B in England. [10002]
Caroline Flint: This information is not held centrally.
Heroin Addicts (Plymouth)
Mr. Streeter: To ask the Secretary of State for Health what the average waiting time is for heroin addicts in Plymouth to access residential treatment. [11332]
Caroline Flint [holding answer 11 July 2005]: Information on waiting times for drug rehabilitation places is published by the National Treatment Agency on a quarterly basis. In March 2005, the average waiting time for residential rehabilitation in Plymouth was five days.
Hospital-acquired Infections
Mr. Lidington: To ask the Secretary of State for Health pursuant to answer of 27 June 2005, Official Report, column 1363W, on Hospital Acquired Infections, during which month this summer she plans to publish the resultsfrom the mandatory surveillance of Clostridium difficile. [9372]
Jane Kennedy [holding answer 4 July 2005]: We expect to publish this data in August.
Infant Formula
Lynne Jones: To ask the Secretary of State for Health if she will press for changes in the Revision of Commission Directive 91/321/EEC on infant formulae and follow-on formulae in order to bring this Directive into line with the International Code and subsequent relevant World Health Assembly Resolutions. [10199]
Caroline Flint:
In the Choosing Health" White Paper, published last November, the Government promised to press for amendments to the European Commission Directive on infant formula and follow-on formula. The Government supports amendments being
18 Jul 2005 : Column 1467W
proposed in the recast directive, which aim to protect the promotion of breastfeeding throughout the European Union.
| Next Section | Index | Home Page |